The Worldwide Flow Cytometry Market for Hospitals & Diagnostic Labs, Academic & Research Institutions and Others - Forecast to 2023 - ResearchAndMarkets.com

The "Flow Cytometry Market for Hospitals & Diagnostic Labs, Academic and Research Institutions and Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023" report has been added to ResearchAndMarkets.com's offering.

The report covers forecast and analysis for the flow cytometry market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million).

The study includes drivers and restraints for the flow cytometry market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the flow cytometry market on a global level.

Market Dynamics

Drivers

• Rising Incidences of HIV & Cancer
• Technological Advancements

Restraints

• The High Cost of the Instrument
• Limited Technical Expertise

Opportunities

• Emerging Role of Flow Cytometry in Drug Discovery & Development

Topics Covered

1. Introduction

2. Executive Summary

3. Market Dynamics

4. Competitive Landscape

5. Technology Segment Analysis

6. Product Analysis

7. Application Analysis

8. End-user Analysis

9. Regional Segment Analysis

10. Company Profiles

• Becton, Dickinson and Company
• Merck Co. Inc.
• Beckman Coulter Inc.
• Thermo Fisher Scientific Inc.
• Sysmex Corporation
• Alere Inc.
• Miltenyi Biotec
• Agilent Technologies Inc.
• Bio-Techne
• Bio-Rad Laboratories Inc.

For more information about this report visit https://www.researchandmarkets.com/research/fl22q2/the_worldwide?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190130005362/en/